Yingdan Cao

3PUBLICATIONS
4CO-AUTHORS
Socio-economic developmentPredictive and prognostic markersEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 01, 2026
Modelling the Clinical and Complication-Related Economic Burden of Therapeutic Inertia in People With Type 2 Diabetes in China.

|Oct 01, 2024
Cost-effectiveness analysis of selpercatinib versus chemotherapy and pembrolizumab in the first-line treatment of rearranged during transfection fusion-positive non-small cell lung cancer in the United States.

Hongbin Yi, Yingdan Cao, Fenghao Shi

|Jul 11, 2024
Cost-effectiveness analysis of amivantamab plus chemotherapy for non-small cell lung cancer patients with epidermal growth factor receptor exon 20 insertions in the United States.

Yingdan Cao, Hongbin Yi, Fenghao Shi

Pageof 1

Frequent Collaborators

2 joint publications

Hongbin Yi

2 joint publications

Fenghao Shi

2 joint publications

Xiaoxia Wei

2 joint publications

Sheng Han